| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/03/1994 | WO1994002506A1 Peptide compounds |
| 02/03/1994 | WO1994002505A1 Compounds which inhibit hiv replication |
| 02/03/1994 | WO1994002504A1 Cytotoxic t-lymphocyte antigen as cysteine protease inhibitor |
| 02/03/1994 | WO1994002502A1 Peptide and protein fusions to thioredoxin and thioredoxin-like molecules |
| 02/03/1994 | WO1994002495A1 Esterification process |
| 02/03/1994 | WO1994002225A1 Sorbent families |
| 02/03/1994 | WO1994002173A1 Multiple particulate antigen delivery system |
| 02/03/1994 | WO1994002169A1 Vaccines against metazoan parasites |
| 02/03/1994 | WO1994002167A1 p53 VACCINE |
| 02/03/1994 | WO1994002163A1 Neuromedin b receptor antagonists |
| 02/03/1994 | WO1994002162A1 Peptide medicaments for treating disease |
| 02/03/1994 | WO1994002108A1 Chemotherapy for cancer |
| 02/03/1994 | WO1994002018A1 Peptides capable of controlling acrosome reaction |
| 02/03/1994 | WO1993024628A3 Sequence of human dopamine transporter cdna |
| 02/03/1994 | WO1993023548A3 Method of detecting tissue-specific fk506 binding protein messenger rnas and uses thereof |
| 02/03/1994 | WO1993021321A3 T CELL EPITOPES OF THE MAJOR ALLERGENS FROM $i(AMBROSIA ARTEMISIIFOLIA) |
| 02/03/1994 | WO1993021303A3 Enhanced purification and expression of insoluble recombinant proteins |
| 02/03/1994 | DE4227454C1 Verfahren zur Früherkennung, zur Erkennung des Schweregrads sowie zur therapiebegleitenden Verlaufsbeurteilung einer Sepsis sowie Mittel zur Durchführung des Verfahrens Methods for early detection, to detect the severity and therapy-accompanying assessment of sepsis and means for carrying out the method |
| 02/03/1994 | DE4225038A1 Herstellung und Verwendung von Antikörpern gegen Kollagen Preparation and use of antibodies against collagen |
| 02/03/1994 | CA2148621A1 Derivatives of bauhinia purpurea lectin and their use as larvicides |
| 02/03/1994 | CA2141301A1 Esterification process |
| 02/03/1994 | CA2140891A1 Peptides useful as internal standards for microsequencing and methods for their use |
| 02/03/1994 | CA2140673A1 Vaccines against metazoan parasites |
| 02/03/1994 | CA2140343A1 Method and reagent for treatment of animal diseases |
| 02/03/1994 | CA2140257A1 Sorbent families |
| 02/03/1994 | CA2140151A1 Peptides that mimic gp120 hiv epitope |
| 02/03/1994 | CA2140132A1 Carboxy terminal il-6 muteins |
| 02/03/1994 | CA2140033A1 Peptide medicaments for treating disease |
| 02/03/1994 | CA2139517A1 Immunological conjugates of ompc and hiv-specific selected principal neutralization epitopes |
| 02/03/1994 | CA2139410A1 Diagnostic method |
| 02/03/1994 | CA2139333A1 Clinical test for detection of alzheimer's disease |
| 02/03/1994 | CA2120014A1 Peptides capable of controlling acrosome reaction |
| 02/03/1994 | CA2118588A1 Neuromedin b receptor antagonists |
| 02/02/1994 | EP0581353A1 Monoclonal antibodies to HiV-1 gp120, cell lines producing them and corresponding epitope structures |
| 02/02/1994 | EP0581329A1 Method of isolating restriction fragment deletions in vibrio cholerae, and products thereof |
| 02/02/1994 | EP0581108A2 Bispecific antibody reactive with sialyl-Lea antigen and CD3 |
| 02/02/1994 | EP0580874A1 Remedy for airway diseases |
| 02/02/1994 | EP0580859A1 Anti-eda monoclonal antibody |
| 02/02/1994 | EP0580829A1 Bacterial protein extract, process for preparing the same and pharmaceutical composition containing said extract |
| 02/02/1994 | EP0580795A1 Antisense oligonucleotides to c-kit proto-oncogene and uses thereof |
| 02/02/1994 | EP0580782A1 An anti-hiv protein, tap 29, from trichosanthes, dna coding therefor and therapeutic uses thereof. |
| 02/02/1994 | EP0580763A1 Compositions and methods for endothelial binding |
| 02/02/1994 | EP0580760A1 Totipotent hematopoietic stem cell receptors -flk-1 and flk-2, and their ligands |
| 02/02/1994 | EP0580758A1 Anti-human immunodeficiency virus recombinant antibodies |
| 02/02/1994 | EP0580752A1 Human bone derived insulin like growth factor binding protein |
| 02/02/1994 | EP0580751A1 Subunit of the human interleukin-3 receptor |
| 02/02/1994 | EP0580737A1 Heterodimeric receptor libraries using phagemids |
| 02/02/1994 | EP0580702A1 Polyamino acid superabsorbents |
| 02/02/1994 | EP0580694A1 Production of phosphopeptides from casein |
| 02/02/1994 | EP0580649A1 Plant promoter involved in controlling lipid biosynthesis in seeds |
| 02/02/1994 | EP0580596A1 Gene mutated in colorectal cancer of humans |
| 02/02/1994 | EP0580594A1 New inhibitors of endothelial cell proliferation |
| 02/02/1994 | EP0408734B1 A method for cleansing streptokinases |
| 02/02/1994 | EP0290446B1 Vaccines for human respiratory virus |
| 02/02/1994 | EP0289597B1 Eucaryotic expression system |
| 02/02/1994 | EP0246307B1 Cys codon-modified dna |
| 02/02/1994 | EP0211047B1 Arab promoters and method of producing polypeptides, includinn cecropins, by microbiological techniques |
| 02/02/1994 | CN1081378A Use of interleukin-10 to induce the production of interleukin-1 receptor antagonist |
| 02/01/1994 | US5283354 Nucleic acids encoding hematopoietic stem cells receptors flk-1 |
| 02/01/1994 | US5283344 Coupling method using selective amination of maleimide |
| 02/01/1994 | US5283323 Complexing antigen to immunoglobulin; sensitivity at low dosage |
| 02/01/1994 | US5283321 Polypeptide compound which binds to glyco-conjugates and to artificial pertussis toxin antigen |
| 02/01/1994 | US5283320 Peptides for HTLV-2 infection diagnosis of, therapy for, vaccination against, for distinguishing between HTLV-1 and HTLV-2 infections and antibodies derived therefrom |
| 02/01/1994 | US5283238 Methods of treating cancer using modified C-reactive protein |
| 02/01/1994 | US5283191 Mareks' disease virus vaccine |
| 02/01/1994 | US5283190 Specific monoclonal antibodies against a defined epitope of progesterone receptor and methods for their use |
| 02/01/1994 | CA1326640C Bacterial strains |
| 02/01/1994 | CA1326639C Nucleic acid encoding tgf-.beta. and its uses |
| 01/31/1994 | CA2101614A1 Synthetic peptides derived from vitronectin and pharmaceutical compositions comprising them |
| 01/31/1994 | CA2101493A1 Bacillus subtilis siderophore genes |
| 01/31/1994 | CA2101468A1 Composition for isolating apamin receptors, apamin binding protein, and uses thereof |
| 01/31/1994 | CA2100600A1 New carbohydrate-based anti-inflammatory agents |
| 01/31/1994 | CA2098463A1 Glucose-regulated promoter of yeast acetyl-coa hydrolase |
| 01/30/1994 | CA2101348A1 Biologically active porcine somatotropin polypeptides and methods of using the same |
| 01/29/1994 | CA2101350A1 Peptides derived from trifluoromethylketones, a process for their preparation and pharmaceutical compositions containing them |
| 01/29/1994 | CA2074790A1 Methods for detecting pre-clinical iddm |
| 01/26/1994 | EP0579958A1 A preventive or therapeutic medicine for pancreatitis |
| 01/26/1994 | EP0579823A1 New hexapeptidic derivatives, preparation, method and application as medicaments of said new derivatives |
| 01/26/1994 | EP0579763A1 Novel peptide compositions and uses therefor |
| 01/26/1994 | EP0579758A1 Parathyroid hormone receptor and dna encoding same |
| 01/26/1994 | EP0579747A1 Method of modulating mammalian t-cell response |
| 01/26/1994 | EP0579742A1 Product and method for improving keratinocyte adhesion to the dermis |
| 01/26/1994 | EP0579739A1 Interleukin-8 receptors and related molecules and methods |
| 01/26/1994 | EP0579730A1 Lantibiotics similar to nisin a, lactic acid bacteria which produce such lantibiotics, method for constructing such lactic acid bacteria and method for preserving foodstuffs with the aid of these lantibiotics and these lactic acid bacteria producing lantibiotics |
| 01/26/1994 | EP0579726A1 Chimeric plant genes based on upstream regulatory elements of helianthinin |
| 01/26/1994 | EP0579685A1 Plasmides for the expression of filamentous haemagglutinin (fha) and hosts therefor |
| 01/26/1994 | EP0579672A1 Xylanase, corresponding recombinant dna sequence, xylanase containing agent, and use of the agent |
| 01/26/1994 | EP0579661A1 Branched peptides in assays for antibodies |
| 01/26/1994 | EP0579640A1 Glial mitogenic factors, their preparation and use |
| 01/26/1994 | EP0579626A1 Method and agents for promoting wound healing |
| 01/26/1994 | EP0579611A1 Peptides |
| 01/26/1994 | EP0579607A1 Prescreening of prostate cancer by serum prostatic specific antigen. |
| 01/26/1994 | EP0579602A1 Vasopressin and vasotocin derivates |
| 01/26/1994 | EP0579597A1 Nucleic acid probes useful for the detection of mycobacterium tuberculosis |
| 01/26/1994 | EP0470117B1 Drugs (calcitonin gene-related peptides) for treating erectile dysfunctions |
| 01/26/1994 | EP0429458B1 Method of inducing lysine overproduction in plants |
| 01/26/1994 | EP0424512B1 Antimetastatic peptides |
| 01/26/1994 | EP0419504B1 Insulin analogues |
| 01/26/1994 | EP0417165B1 Polypeptide compounds having growth hormone releasing activity |
| 01/26/1994 | EP0366684B1 Ibdv vp2 epitope recognised by virus neutralising and protective monoclonal antibodies |